ScholarIQanswers from OpenAlex & ORCID
K. J. Schjoedt
ResearcherPublications, citations & collaboration network
K. J. Schjoedt is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does K. J. Schjoedt have?
ScholarIQindexed works
K. J. Schjoedt has 17 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does K. J. Schjoedt have?
ScholarIQcitation count
K. J. Schjoedt has 1,808 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of K. J. Schjoedt?
ScholarIQh-index
K. J. Schjoedt has an h-index of 14 in OpenAlex.
What is the i10-index of K. J. Schjoedt?
ScholarIQi10-index
K. J. Schjoedt has an i10-index of 15 in OpenAlex.
What is the OpenAlex record for K. J. Schjoedt?
ScholarIQopenalex
The OpenAlex for K. J. Schjoedt is on the source record.
What are the most-cited papers on K. J. Schjoedt?
ScholarIQmost cited works
Beneficial Effects of Adding Spironolactone to Recommended Antihypertensive Treatment in Diabetic Nephropathy
Kasper Rossing, K. J. Schjoedt, U. Smidt, Frans Boomsma, Hans‐Henrik Parving
Aldosterone escape during blockade of the renin?angiotensin?aldosterone system in diabetic nephropathy is associated with enhanced decline in glomerular filtration rate
K. J. Schjoedt, Steen Andersen, Peter Rossing, Lise Tarnow, Hans‐Henrik Parving
Beneficial impact of spironolactone in diabetic nephropathy
K. J. Schjoedt, Kasper Rossing, Tina R. Juhl, Frans Boomsma, Peter Rossing, Lise Tarnow, Hans‐Henrik Parving
Enhanced renoprotective effects of ultrahigh doses of irbesartan in patients with type 2 diabetes and microalbuminuria
Kasper Rossing, K. J. Schjoedt, Berit R. Jensen, Frans Boomsma, Hans‐Henrik Parving
Beneficial impact of spironolactone on nephrotic range albuminuria in diabetic nephropathy
K. J. Schjoedt, Kasper Rossing, Tina R. Juhl, Frans Boomsma, Lise Tarnow, Peter Rossing, H.-H. Parving